Welcome to our dedicated page for Innospec SEC filings (Ticker: IOSP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Innospec Inc. filings document the financial reporting, governance and capital-return disclosures of a specialty chemicals operating company. Form 8-K reports record quarterly and annual results, segment commentary for Performance Chemicals, Fuel Specialties and Oilfield Services, Regulation FD disclosures, semi-annual dividends and board-authorized common stock repurchase programs.
The company’s proxy materials describe annual meeting matters, director elections, executive compensation votes, auditor ratification and related governance procedures. Its filings also identify IOSP common stock as a NASDAQ-listed security and provide formal disclosure around results of operations, financial condition, risk-related business context and shareholder voting matters.
INNOSPEC INC. senior vice president, general counsel and chief compliance officer David B. Jones acquired 1,903 shares of common stock on February 16, 2026 through the settlement of a performance-based restricted stock unit award originally granted on February 27, 2023. The award carried no cash purchase price per share. Following this equity grant, Jones directly holds a total of 13,603 shares of Innospec common stock.
Innospec Inc. reports full-year 2025 results, with net sales of $1,778.0 million, down 4% from 2024 as lower Oilfield Services revenue offset modest growth in Performance Chemicals.
Net income rose to $116.6 million from $35.6 million, helped by the absence of a prior-year pension settlement charge. Fuel Specialties delivered 12% higher operating income on stronger mix and pricing, while Performance Chemicals and Oilfield Services saw margin pressure and, in 2025, asset and intangible impairments. Cash and cash equivalents were $292.5 million with no debt, and cash from operations after capital expenditures was $63.9 million. The company paid dividends of $1.71 per share and repurchased 264,000 shares for $23.9 million.
Innospec Inc. reported mixed fourth-quarter and full-year 2025 results, with solid profitability but lower sales and underlying earnings. Fourth-quarter revenue was $455.6 million, down 2%, while net income swung to a profit of $47.4 million, or $1.91 per diluted share, compared with a prior-year loss driven by a UK pension buyout charge. Adjusted non-GAAP EPS rose to $1.50 from $1.41, and adjusted EBITDA was essentially flat at $55.7 million.
For 2025, revenue declined 4% to $1.78 billion and adjusted EBITDA fell 10% to $203.0 million. Full-year net income improved to $116.6 million, or $4.67 per diluted share, largely reflecting the absence of the prior-year UK pension scheme settlement. However, adjusted non-GAAP EPS decreased to $5.27 from $5.92, showing softer underlying performance.
Fuel Specialties was a bright spot, with 2025 operating income up 12% to $144.8 million, while Performance Chemicals and Oilfield Services saw lower annual operating income. Cash generation remained strong: operating cash flow was $138.3 million for the year, and Innospec ended 2025 with net cash of $292.5 million, giving it balance sheet flexibility for dividends, buybacks, investment and M&A.
Innospec Inc. director reports open-market stock purchase
A director of Innospec Inc. (IOSP) reported buying 340 shares of the company’s common stock on 11/14/2025 at a price of $74.09 per share. After this transaction, the director beneficially owns 5,837 shares, held as a direct ownership position. The transaction was reported on a Form 4 as a purchase coded "P" in the non-derivative securities table, and no derivative security transactions were reported.
Innospec Inc. (IOSP) reported third-quarter 2025 results. Net sales were $441.9 million versus $443.4 million a year ago. Operating income fell to $5.9 million from $45.6 million, and net income was $12.9 million, or $0.52 diluted EPS, compared with $33.4 million, or $1.33 diluted EPS.
Segment trends were mixed. Performance Chemicals sales rose 4% to $170.8 million but gross margin declined to 15.1% on pricing erosion and mix. Fuel Specialties grew 4% to $172.0 million with gross margin up to 35.6% on improved mix and disciplined pricing. Oilfield Services declined 13% to $99.1 million, while gross margin improved to 30.0% on mix.
Results included a $22.9 million impairment of property, plant and equipment and a $19.1 million impairment of intangible assets, partly offset by a $17.7 million credit from contingent consideration revaluation. Cash and cash equivalents were $270.8 million with no borrowings on the $250.0 million revolver. Year-to-date operating cash flow was $76.9 million; the company paid dividends of $20.8 million and repurchased $23.9 million of common stock. Shares outstanding were 24,777,582 as of October 31, 2025.
Innospec Inc. reported that it issued a press release announcing its financial results for the fiscal quarter ended September 30, 2025. The company also declared a semi-annual dividend of $0.87 per share on its common stock.
The dividend will be paid on November 26, 2025 to shareholders of record as of November 18, 2025. The press release was furnished as Exhibit 99.1, providing details on the quarter’s performance.
Innospec’s Q2 2025 10-Q shows mixed performance. Net sales rose 1% YoY to $439.7 m, but net income fell 25% to $23.5 m (EPS $0.94). Lower profitability stemmed from a 120 bp drop in aggregate gross margin to 28.0% and a 3% rise in operating expenses; operating income declined 16% to $34.3 m.
Segment results were uneven: Fuel Specialties boosted gross margin 350 bp to 38.1% and operating income 16% to $35.4 m, while Performance Chemicals margin contracted 510 bp and Oilfield Services revenue fell 7%. For the first half, sales slipped 6% to $880.5 m and net income dropped 22% to $56.3 m (diluted EPS $2.24).
Cash from operations shrank to $37.6 m (-56% YoY) as inventories climbed $35.8 m. Nevertheless, cash & equivalents remain solid at $266.6 m; the $250 m revolver is undrawn and the company carries no long-term debt. Equity improved to $1.30 bn on retained earnings and a $57.6 m favorable FX translation adjustment.
Capital deployment included $32.2 m of capex/ERP spend, $20.8 m dividends ($0.84 / share) and $13.3 m share buybacks under a new $50 m program. Plant-closure provisions were raised $4.1 m and FX hedges produced a $6.4 m loss. Management cites softer demand in Oilfield Services and price pressure in Performance Chemicals, but highlights margin gains in Fuel Specialties and low leverage.